Fate Therapeutics
FATE
FATE
163 hedge funds and large institutions have $401M invested in Fate Therapeutics in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 59 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 59
43% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 35
Holders
163
Holding in Top 10
1
Calls
$239K
Puts
$35K
Top Buyers
| 1 | +$7.22M | |
| 2 | +$3.39M | |
| 3 | +$1.71M | |
| 4 |
Goldman Sachs
New York
|
+$1.66M |
| 5 |
BlackRock
New York
|
+$1.25M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$3.96M | |
| 3 | -$3.39M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.85M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.45M |